Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here are their news releases. Looks like a business to me.
http://www.otcmarkets.com/stock/DYNV/news
http://www.otcmarkets.com/stock/DYNV/news
http://www.otcmarkets.com/stock/DYNV/news
http://www.otcmarkets.com/stock/DYNV/news
They did $3.5MM in revenue for the year ended 2010, showing a loss of 156K. This year looks to be a lot higher and assuming the gross margins stay the same, the company should be profitable.
Initially I did. I believe the stories management told me about impending sales. Then I wised up and saw this for what it was, a continual pump and dump. I made back my money, but it took a while.
My guess is you have no clue what it takes. XenTx has been around a long time. I don't believe they have filed any patents on that or the Diesel product. If they did file a patent, they are protected unless they are violating someone elses or someone filed a similar patent before them. All they do is tout results with zero backing. They fuzzy up their financial press releases to make it seem like they are doing well, when in fact they were losing money. Good companies don't do that.
Except for the fact the company is actually building a successful business. The biggest mistake a lot of startups make is reverse merging into a shell without knowing all the players. That seems to be the case here.
None of these predictions are coming. Where are all these big orders. Testing was supposed to be completed and has been completed on a number of projects months and months ago. No order though. Funny how that slips your mind. You'll be gone once the pumping is over. One week two weeks, its going to end that is certain and then this stock will be back in sub penny land. They have zero cash. How do you operate a business that way?
If your gross profit is 15% you are never going to make money, not unless you are doing billions in sales. Last year they did 59.5 million in sales, so they were actually down quite a bit. Are you sure that the past isn't relevant. Why would the company be telling the truth now? Did you know the company announced that its Diesel product got TxLED approval and then lost it. They never announced that they lost it. Then a year later came out with same release saying they had gotten it? Those who fail to study history are doomed to repeat it. Check this company's history of announcements and you can see anybody who has followed the company for more than three years can be skeptical. Most of you guys are simply pumpers who have gotten paid with shares trying to drum up an audience. I wish you could buy XenTx in Walmart, Pep Boys, Target etc. like you used to, but you can't. Thankfully got a boatload on clearance from Pep Boys that I won't need any for a long time.
To all new shareholders who are interested in how well the company's predictions come to fruition, I suggest you read the letter issued to shareholders almost a year ago. Here is the link. http://www.globenewswire.com/newsroom/news.html?d=194265 Prediction after prediction has come to naught.
Looks to me like some third party payor stuff. Not generated by the company itself, but by some shareholders who got cheap shares and are looking to exit out. The company just hired a legitimate Investor Relations firm. This group works with Unilife a Nasdaq company.
Investing, nice try, but you posted a cached page there. Here is what it said today.
The previous BUY recommendation was issued on 04.20.2011 (1) day ago, when the stock price was 4.9200. Since then UNIS has gained 1.63% .
The previous BUY recommendation was issued on 04.20.2011 (1) day ago, when the stock price was 4.9200. Since then UNIS has gained 1.63% .
Its always tomorrow with you paid pumping crew. It was supposed to be Monday that the shorters had to worry. Now its next week.
Hoss,you have to learn how to read financials. Please, that profit was a complete accounting mirage. They basically created a financial transaction that was booked as a pure profit, although money didn't change hands. Look at their operating profit if you want to see how well they are doing. They were down to less than 100K in the bank and owe the US Govt 99K per month. They settled a debt and are paying 8K per month on that. Add those two up and what do you get? No money in the bank.
UNIS Buy confirmed American Bulls
http://www.americanbulls.com/StockPage.asp?CompanyTicker=UNIS&MarketTicker=NASD&TYP=S
Put that in your pipe and smoke it investing123
Investing, Americanbulls is wrong as much as it is right. Last time they confirmed a sell the stock was up.
Investing, you are clearly confused by what the money maker for the company is going to be, so let me help you out and explain it to you. Its the prefilled syringes that will be driving force for the company and why they built the 165,000 sq ft plant. The Unitract syringe is a completely different product and a different market. Unifill Syringes will carry much higher GP% and will be purchase in huge quantities for filling. Totally different end user on these items. Why do you suppose Sanofi put in $30 million or so to develop these syringes, its because they plan on using about 1 billion or so a year in the future.
Lars, you clearly no nothing about business. The busing companies will not pass along the savings. Be serious, they make more profit. Why do you think the oil companies are making so much money? The price of actually extracting oil has gone down over time, it stands around $12 per barrel. Are they passing any saving onto us? Uh no.
Shotcaller is correct. First off most schools do not own their own buses. They contract that out, so the school isn't going to be saving anything. So no new teachers. All fluff.
Investing123, if you want to delude yourself, be my guest. Those patents are the property of Unilife. As far as the shelf registration, that is standard practice for most corporations who want to raise capital at some future date. Its a lot cleaner than doing an S-1 registration. The company has its intellectual property intact, they have an FDA approved product, they have the largest user of prefilled syringes paying for the industrialization of the Unifill product. They have $30 million in the bank and have managed to cut expenses to save an additional $7 million. You want me to worry about some company that was issued a patent in the same area. Keep dreaming. Who do they have backing them? Nobody.
Investing, what you put up was a post effective amendment. Here is the listing of the intellectual property for the company. You can find it under the Intellectual Property heading of the 10K. Do you think that Sanofi would pay them $30 million for the right to use the syringe in a few categories if they didn't research the intellectual property on it first. Please use your head. This is from the most recent 10K.
Intellectual Property
We have established an intellectual property portfolio through which we seek to protect our products and technology. Our intellectual property portfolio includes 32 granted patents in 16 countries, with four issued patents each in Australia and two in the United States. We have filed a significant number of patent applications that are now pending in Australia, the United States, Europe, China, India and other countries covered under the Patent Cooperation Treaty. We also hold provisional patent applications in both the United States and Australia and several registered trademarks. Our patents expire at various dates between 2018 and 2028. Patents relating to the Unifill syringe are expected to expire by 2028. Trade secrets law in the United States and other jurisdictions provides additional protection. We also enter into non-disclosure agreements with certain vendors and customers. All active United States based employees have signed confidentiality, non-compete and intellectual property assignment agreements.
We classify our patents and patent applications as they relate to particular product categories including 1mL insulin and safe syringes with an attached needle; clinical syringes which include larger sizes and interchangeable luer needles; and our Unifill syringe. Many of the features claimed in the insulin and safe syringes patents, such as the mechanism allowing automatic and controlled needle retraction within an integrated medical device, also apply to our other safety syringe products, including the Unifill syringe. Some key patents covering countries such as Australia, the United States and Europe, as well as some of our international patent applications, are described below:
INSULIN AND SAFE SYRINGE (UNITRACT)
Issued
Description Patent No. Patent Application No. Publication No. Patent Expiry Date
Australian Patent 731159 September 22, 2018
U.S. Patent 6,083,199 September 22, 2018
International
Patent Application PCT/AU01/000458 WO 01/80930 April 20, 2021
Europe 01925194.1 1 276 530 A April 20, 2021
USA 7,500,967 20030158525 July 15, 2022
International
Patent Application PCT/AU2004/000354 WO 2004/082747
Europe 04721775.7 1 608 421A March 19, 2024
USA 10/549,710 20060235354 March 19, 2024 *
* subject to possible patent term adjustment
The patents listed above cover the following features of the insulin and safe syringe:
• a plunger with interconnecting slots and gates to proved rotation into the injection stroke and then the lockout stroke;
• a compressed spring to retract the needle and rotate the plunger into a locked position to prevent sharps exposure; and
• a plastic mount on the needle to provide a needle pickup by the plunger for needle retraction.
13
--------------------------------------------------------------------------------
Table of Contents
CLINICAL SYRINGE
Issued
Description Patent No. Patent Application No. Publication No. Patent Expiry Date
International Patent Application PCT/AU2005/000107 WO 2005/072801
Europe 05700138.0 1 708 772 January 28, 2025
USA 10/587,705 20080255513 January 28, 2025 *
International Patent Application PCT/AU2006/000618 WO 2006/119570
Europe 06721494.0 1 879 635A May 11, 2026
USA 11/914,092 20090221962 May 11, 2026 *
USA 61/160,253 November 11, 2029
* subject to possible patent term adjustment
The patents listed above cover the following features of the clinical syringe:
• a plunger that holds a compressed spring that is used to retract a luer mount needle from the end of the barrel;
• a plunger that retracts a luer mount needle into the barrel with controlled reaction;
• a luer mount needle that is mounted in the barrel with retaining clips integrally formed in the barrel and which uses an ejector to release the needle; and
• a clinical syringe with a proprietary changeable needle with controlled retraction.
READY TO FILL SYRINGE (UNIFILL)
Issued
Description Patent No. Patent Application No. Publication No. Patent Expiry Date
International Patent Application PCT/AU2006/000516 WO 2006/108243
Europe 06721397.5 1 868 669 April 18, 2026
USA 11/911,481 2009093759 April 18, 2026
International Patent Application PCT/AU2008/000971 WO 2009/003234 A1
Europe 08757038.8 July 2, 2028
USA 12/666,448 July 7, 2028
USA 61/260,252 November 11, 2029
USA 61/289,259 December 22, 2029
USA 61/331,197 May 14, 2030
The patents listed above cover the following features of the Unifill syringe:
• a two-piece plunger seal and a needle seal with an ejector;
• a plunger that is molded with a needle pickup feature;
• a plunger where the control rod is broken off to reduce the disposal length;
• a needle retainer and release ring that are glued to a glass barrel to overcome limited moldability of glass;
• a needle retainer, ejector ring and needle seal that retain the needle mount until released for retraction after the full dose is administered;
• a proprietary changeable needle with controlled retraction; and
• a plastic barrel adapter mounted to a parallel glass barrel for simplified manufacture, with controlled retraction.
An issued patent, unlike a pending patent application, has been reviewed by the relevant national patent office and has met the legal requirements for patentability required by the law of that country.
Sounds like someone who has done real due diligence on the stock. My statement wasn't an opinion it was fact. You can't argue with them so you would rather avoid that issue entirely. Its no skin of my back.
Smokestack, do you know how many times the company has said that exact same thing? Every earnings release. You notice how they said nothing about their profitability only sales. Nothing about their cash position either. Tenuous at best. This happens every year, the only difference is that the highs this stock achieves is significantly lower than the last one on the same kind of pump. The lows go only lower. Volume has been nominal at best. So far about dollar volume is 25K, not a glowing endorsement for the company in my books.
The fins are not out, just a PR piece stating revs and GP. The real fact about this PR piece is that revs declined from the third quarter ending 12/31/2010 by $1.1 million, a downward trend. GP of 15.5% for the March 31, 2011 quarter translates into roughly $1,250,000 on the $8.1 in revs. This is not much and if SGA remained the same as the previous quarter of $1.9 million, the Company will report a loss of at least $650,000 for the quarter before counting depreciation, amortization and interest.
With those types of losses, it is hard to imagine how they can pay off their quarterly tax commitment of $297,000.
I don't characterize those as good results.
Unilife has its own patent portfolio, I highly doubt this would have anything to do with the stock movement. Did you even read that patent?
The stagnation in the price has more to do with the lack of movement in Australia than it does have anything to do with here. The shelf registration is something that most companies on Nasdaq put out so they have "dry powder" to raise capital if and when and how the need arises. Its a lot better than an S-1 filing because it doesn't send a flare into the sky that says short me now because I'm doing an offering at a discount. I'm more discourage by the lack of follow through from the Australian side of the stock.
Cash money, gimme a break. The stock barely trades. So what you got a 50% gain on 100 bucks. It will take you a 1000 years to make what I made on UNIS or DYSL's moves. I'm a long term investor and most people are. The people who saying this going to 20 cents will be out if this is lucky enough to hit a nickel. Then it will be back in the sub penny range where it belongs. The company has put out more misleading press releases than Enron. I'm actually surprised they are still in business. They owe the US Govt 99K per month, now and old debt holder 8K per month. This adds up to more cash than they reported on the books last quarter. Not a good sign. I suspect that when the shares underlying the latest conversion are available to trade there will be another major attempt to pump this up. This one is so the founders can get out the shares that they took for converting their debt. IMHO
WayCoolJr, I don't use either service because its basically a snapshot of yesterday's information. But the Barchart site has been used a few times to validate this an investment, so I was just countering the opinion. It was a douche manuveur on my part, but when some of the posters only retort is to say well if you don't like the stock you should leave, I get annoyed. I used to like this company, but management screwed it. Now the stock itself may see a momentary rise, but it will eventually make new lows because you have a bunch of people running this like its their kingdom.
Here's what american bulls has to say,
http://www.americanbulls.com/StockPage.asp?CompanyTicker=GNPG&MarketTicker=OTC&TYP=S
Sorry you don't like what I have to say. All you do is hump stocks all day. I suggest you try and refute what I have had to say. Too bad all you'll do is say why are you here? As I have said, I love the XenTx product. Too bad you can't buy it any stores other than O'Reilly's if they still even carry it. I bought I a lifetime supply when Pep Boys discontinued it. The rest of the story has been puffery. They've paid numerous websites and stockpumpers to move this thing and its basically played out. 100 million plus in the float and very little volume to show for it. If you want low float stocks, you should have been in DYSL or UNIS the last two weeks. In and out for big gains.
WayCool, I find no reason to actually pay for this service. If I have to post more than 15 times in a day, then I have other issues. Its just as easy to post the question in the forum so you can multiple answers and perspectives.
KSA - Anytime - feel free to ask questions. That's the whole point of these forums.
KSA - the conversion price is the conversion price. It converts to 32 cents, but the holder doesn't really care about that. He wants two things, the interest payment and to be paid off. For the company its a win on the P&L statement if they can pay it off in part because they can make it look like a gain. Paying off a debt for half of what you owe works out as a profit in an accountants mind. The dilution is nominal. What's 5 million more shares when you already have 150MM out there. Its 3.33%. Big deal. This PR was put out to try and stoke the fires of people who don't read financial reports. Its looks good on paper, but that's about it.
KSA - you are wrong in this case. You are forgeting that they are converting 1.5 mm of debt into preferred shares paying interest at 8K per month. So the conversion into common shares is at 32 cents. Now these preferred shares will be in perpetuity unless the company redeems them. The company can redeem them at 1/2 price essentially. They get double credit as long as they buy more than 200K, I believe. They still have a ton of debt on the books, so this was really no big deal. The noteholders probably view getting 8k per month better than the zero they had been receiving. If the company can redeem the shares at least it wouldn't have been a total loss on the notes. Its a win win for both sides, providing that the company makes the interest payments. I don't know what if any penalties there may be for missing them.
great of the shares that were traded only 75-80k were buys, the rest sells. That news was BS and already reported in the 10Q. Here it is pulled straight from the Dec report.
During the quarter ended December 31, 2010, the Company entered into an agreement with the holder of the Purchase note payable to convert the outstanding debt to Series A Preferred Stock, abate $191,699, $0.00 per weighted average common share outstanding, of interest accrued and pay preferred dividends of $8,000 per month. The preferred stock is convertible to common stock at any time the common stock price is in excess of $0.32 per share.
This company has a terrible habit of repeating news that is already out.
and how do you know there will be a PR in the AM?
I don't think the consolidation will happen here. There are very few shares on Nasdaq available. Now with renewed buying we could see a short squeeze here. Any real good news we could see a major run.
You guys are really smacking that ask around aren't you....nice work
spoken like a true pundit. No facts, just conjecture. I hope you light this up, so I can go short again on this turd. They have no money, they owe more than they are even coming close to bringing in. Can't you read a balance sheet or a P&L statement? You said, you were buying at 1.8 and 1.9 cents. So how come you've stopped and the stock is at 1.6 cents on the offer? You know why? Because you hadn't really bought anything had you.
Hopefully it can keep up the momentum and get up into the 6s again. We are coming up on the anniversary of the 52 week high so that will start to come down giving some momo guys some incentive to jump in when it reaches its 52 week again.
No need, I've seen what this stock can do and its just going to sink to new lows soon enough. I haven't been wrong yet on this one and I won't be this time either. You clearly have stopped buying this stock and so has everyone else. There are no more suckers left to dupe. The company had less than 100K left in the bank and they owe the IRS 99K per month. How much do they have left in the till?
I could post every single inane thing you've stated on this forum, but I'd have too much trouble typing and laughing at the stupidity. Here's your most telling comment http://investorshub.advfn.com/boards/read_msg.aspx?message_id=60428265
you said the same thing last week and the week before...nothing is going to happen with this stock...its toast